封面
市场调查报告书
商品编码
1455792

全球黄酮苷市场 - 2024-2031

Global Flavonoid Glycosides Market - 2024-2031

出版日期: | 出版商: DataM Intelligence | 英文 213 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023年,全球黄酮苷市场达到3.871亿美元,预计2031年将达到6.406亿美元,2024-2031年预测期间CAGR为6.5%。

由于对合成添加剂和人造物质的担忧,消费者越来越偏好天然成分製成的产品。源自植物和水果的类黄酮苷顺应了天然和清洁标籤产品的趋势。因此,对含类黄酮苷产品的需求不断增加,从而推动了市场成长。

正在进行的研究和开发工作的重点是探索类黄酮苷的健康益处和治疗潜力。研究证明这些化合物具有抗氧化、抗发炎和抗菌特性,导致它们在药品、营养保健品和功能性食品中的使用增加,从而扩大了黄酮苷在各行业的应用。

例如,2023年9月5日,赢创在SPACE 2023上推出了其单胃产品组合的新增强功能。它正在推出PhytriCare IM:赢创产品组合的最新成员,这种预混剂标誌着上镜产品的首次亮相。它富含黄酮类化合物,可为母猪、蛋鸡和乳牛的发炎管理提供潜在益处。

由于其抗氧化特性,类黄酮苷通常用作膳食补充剂中的活性成分。随着消费者越来越多地转向补充剂来满足其营养需求,对含类黄酮苷补充剂的需求不断增加,从而促进了市场成长。製造商透过推出由天然成分(包括类黄酮苷)製成的新产品来满足消费者的喜好。对天然和清洁标籤产品的关注正在推动北美市场的成长。

动力学

对功能性食品和营养保健品的需求不断增长

随着消费者对功能性食品和营养保健品的健康益处的认识不断增强,对富含类黄酮苷等生物活性化合物的产品的需求也相应增加。食品和饮料製造商可能会推出更多含有这些化合物的产品来满足这项需求,从而扩大市场。

对功能性食品和营养保健品的需求鼓励了食品产业的创新和产品开发。製造商不断探索新的配方和输送系统,以提高黄酮苷等生物活性化合物的生物利用度和功效。这项创新为消费者提供了更广泛的产品选择,从而推动了市场成长。

例如,2023 年 9 月 14 日,Uncle Matt's Organic 推出了「better-for-you」饮料系列的新成员:Superfruit Punch。它由黑甜樱桃、黑接骨木浆果和蓝莓混合製成,这种功能性果汁富含抗氧化剂、多酚和类黄酮。 Uncle Matt 的潘趣酒专为注重健康的消费者而设计,每 8 盎司仅含有 45 卡路里热量,不添加糖或香料,也绝对不含防腐剂。

扩大在製药业的应用

类黄酮苷传统上因其治疗特性而用于各种文化的草药系统。随着人们对自然疗法和草药补充剂的日益青睐,对含有类黄酮苷的药品的需求也不断增加。需求的增加直接促进了黄酮苷市场的成长。

製药公司正在大力投资研发,探索黄酮苷的药用特性及其在治疗和预防各种疾病的潜在应用。例如,2024 年 2 月 29 日,Ingredients by Nature 宣布在 BioFactors Journal 上发表其实验研究,重点关注 Eriomin,一种获得多项专利的柑橘类黄酮混合物。该研究深入探讨了 Eriomin 促进肝功能和解决与年龄相关的肝臟问题的潜力。

原料供应有限

类黄酮苷主要来自水果、蔬菜和草药等天然来源。气候变迁、自然灾害和季节变迁等因素可能会扰乱这些原料的供应链。原材料供应中断可能导致产量波动,影响市场成长。市场参与者面临从多个地区采购原材料的挑战,导致供应短缺并阻碍市场成长。

含有黄酮苷的植物有特定的采收季节,此时原料丰富,品质最佳。原材料供应量下降,导致维持稳定生产水准面临挑战。市场参与者需要储存原材料并投资储存设施,以减轻季节性变化的影响,从而增加生产成本并可能影响市场成长。

目录

目录

第 1 章:方法与范围

  • 研究方法论
  • 报告的研究目的和范围

第 2 章:定义与概述

第 3 章:执行摘要

  • 按类型分類的片段
  • 来源片段
  • 按应用程式片段
  • 按地区分類的片段

第 4 章:动力学

  • 影响因素
    • 司机
      • 对功能性食品和营养保健品的需求不断增长
      • 扩大在製药业的应用
    • 限制
      • 原料供应有限
    • 机会
    • 影响分析

第 5 章:产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 俄乌战争影响分析
  • DMI 意见

第 6 章:COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆发前的情景
    • 新冠疫情期间的情景
    • 新冠疫情后的情景
  • COVID-19 期间的定价动态
  • 供需谱
  • 疫情期间政府与市场相关的倡议
  • 製造商策略倡议
  • 结论

第 7 章:按类型

  • 槲皮素-3-O-芸香苷 (Q-rut)
  • 槲皮素-3-O-半乳糖苷 (Q-gal)
  • 槲皮素-3-O-葡萄糖苷 (Q-glc)
  • 槲皮素-3-O-葡萄醣醛酸苷 (Q-glr)
  • 山奈酚-3-O-葡萄糖苷 (K-glc)
  • 其他的

第 8 章:按来源

  • 柑橘类水果
  • 荞麦
  • 洋葱
  • 其他的

第 9 章:按应用

  • 抗癌
  • 抗氧化剂
  • 消炎剂
  • 其他的

第 10 章:按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 俄罗斯
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 亚太其他地区
  • 中东和非洲

第 11 章:竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 12 章:公司简介

  • Merck KGaA
    • 公司简介
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Merck KGaA
  • Lifecare Neuro Products Limited
  • Indena SpA
  • Cayman Chemical Company
  • Extrasynthese
  • INDOFINE Chemical Company, Inc.
  • SMPNutra
  • Taylor & Francis Group, LLC.
  • Ayur-vana
  • Ingredion Incorporated [List not Exhaustive]

第 13 章:附录

简介目录
Product Code: FB8251

Overview

Global Flavonoid Glycosides Market reached US$ 387.1 million in 2023 and is expected to reach US$ 640.6 million by 2031, growing with a CAGR of 6.5% during the forecast period 2024-2031.

Growing preference among consumers for products made with natural ingredients, driven by concerns about synthetic additives and artificial substances. Flavonoid glycosides, derived from plants and fruits, align with this trend toward natural and clean-label products. As a result, there is increasing demand for flavonoid glycoside-containing products, which is driving market growth.

Ongoing research and development efforts are focused on exploring the health benefits and therapeutic potential of flavonoid glycosides. Studies have demonstrated the antioxidant, anti-inflammatory, and antimicrobial properties of these compounds, leading to their increased use in pharmaceuticals, nutraceuticals, and functional foods expanding the applications of flavonoid glycosides in various industries.

For instance, on September 5, 2023, Evonik introduced new enhancements to its monogastric portfolio at SPACE 2023. It is introducing PhytriCare IM: Evonik's newest addition to the portfolio, this premix marks the debut of photogenic products. It is infused with flavonoids, it offers potential benefits in inflammation management for sows, laying hens, and dairy cows.

Flavonoid glycosides are commonly used as active ingredients in dietary supplements due to their antioxidant properties. As consumers increasingly turn to supplements to meet their nutritional needs, the demand for flavonoid glycoside-containing supplements is on the rise, contributing to market growth. Manufacturers are responding by introducing new products made with natural ingredients, including flavonoid glycosides, to cater to consumer preferences. This focus on natural and clean-label products is boosting market growth in North America.

Dynamics

Rising Demand for Functional Foods and Nutraceuticals

As consumer awareness about the health benefits of functional foods and nutraceuticals grows, there is a corresponding increase in demand for products enriched with bioactive compounds such as flavonoid glycosides. Food and beverage manufacturers are likely to introduce more products containing these compounds to cater to this demand, thereby expanding the market.

The demand for functional foods and nutraceuticals encourages innovation and product development within the food industry. Manufacturers are continually exploring new formulations and delivery systems to enhance the bioavailability and efficacy of bioactive compounds like flavonoid glycosides. This innovation fuels market growth by offering consumers a wider range of products to choose from.

For instance, on September 14, 2023, Uncle Matt's Organic introduced its new addition to the better-for-you beverage lineup: Superfruit Punch. It is crafted with a combination of dark sweet cherries, black elderberry, and blueberries, this functional juice is rich in antioxidants, polyphenols, and flavonoids. It is designed for health-conscious consumers, Uncle Matt's punch boasts just 45 calories per 8-oz serving, with no added sugars or flavors, and absolutely no preservatives.

Expanding Applications in the Pharmaceutical Industry

Flavonoid glycosides are traditionally used in herbal medicine systems across various cultures for their therapeutic properties. With the growing preference for natural remedies and herbal supplements, there is an increased demand for pharmaceutical products containing flavonoid glycosides. This increased demand directly contributes to the growth of the flavonoid glycosides market.

Pharmaceutical companies are investing heavily in research and development to explore the medicinal properties of flavonoid glycosides and their potential applications in the treatment and prevention of various diseases. For instance, on February 29, 2024, Ingredients by Nature announced the publication of its experimental research in the BioFactors Journal, focusing on Eriomin, a multi-patented citrus flavonoid blend. The study delves into the potential of Eriomin to promote liver function and address age-related liver concerns.

Limited Availability of Raw Materials

Flavonoid glycosides are primarily derived from natural sources such as fruits, vegetables, and herbs. Factors such as climate change, natural disasters, and seasonal variations can disrupt the supply chain of these raw materials. Interruption in the availability of raw materials can lead to fluctuations in production output, affecting market growth. Market players face challenges in sourcing raw materials from multiple regions, leading to supply shortages and hindering market growth.

The plants containing flavonoid glycosides have specific harvesting seasons, during which the raw materials are abundant and of optimal quality. The availability of raw materials declines, leading to challenges in maintaining consistent production levels. Market players need to stockpile raw materials and invest in storage facilities to mitigate the impact of seasonal variations, adding to production costs and potentially affecting market growth.

Segment Analysis

The global flavonoid glycosides market is segmented based on type, source, application, and region.

Increasing Demand for Antioxidant-Rich Products

Antioxidant holds the largest share of the global market. There is a growing awareness among consumers about the health benefits of antioxidants, including their role in neutralizing free radicals and reducing oxidative stress. As a result, there is a rising demand for antioxidant-rich products, such as dietary supplements, functional foods, and beverages, which contain flavonoid glycosides. This increased demand boosts market growth within the antioxidant segment.

Ongoing development focused on exploring the therapeutic potential of antioxidants in preventing and treating various diseases. Clinical studies investigating the efficacy of flavonoid glycosides and other antioxidants have generated promising results, further supporting their use in healthcare products. The positive outcomes of such research contribute to market growth within the antioxidant segment.

Geographical Penetration

Increasing Consumer Awareness and Innovations in North America

North America dominates the global flavonoid glycosides market. North America has a well-developed health and wellness industry, and consumers in the region are increasingly aware of the health benefits associated with flavonoid glycosides. There is a growing interest in natural and plant-based ingredients, including flavonoid glycosides, due to their antioxidant properties and potential health-promoting effects boosts demand for flavonoid glycoside-containing products in the region, contributing to market dominance.

North America has several major players in the food, beverage, dietary supplement, and pharmaceutical industries, which are actively involved in the production and distribution of flavonoid glycosides. These companies have extensive research and development capabilities, robust distribution networks, and strong brand recognition, enabling them to dominate the flavonoid glycosides market in the region.

COVID-19 Impact Analysis

The pandemic led to disruptions in global supply chains due to lockdown measures, travel restrictions, and workforce shortages. This disruption affected the sourcing of raw materials for flavonoid glycoside extraction, as well as the transportation of finished products. Consequently, market players faced challenges in maintaining production levels, leading to potential delays in product availability and fulfillment of orders, which could have hindered market growth.

The pandemic prompted significant shifts in consumer behavior, including changes in dietary preferences and purchasing patterns. With a heightened focus on health and wellness, consumers increasingly sought out products with immune-boosting and antioxidant properties, including those containing flavonoid glycosides. This shift in consumer demand could have bolstered market growth, as manufacturers responded by introducing new products or marketing existing ones emphasizing their flavonoid glycoside content.

Russia-Ukraine War Impact Analysis

During the conflict, disruptions occurred in the agricultural supply chains of both Russia and Ukraine, two significant exporters of raw materials used in flavonoid glycoside extraction. This disruption led to shortages and price volatility for raw materials, hindering production capabilities. Consequently, market growth was constrained due to reduced availability and increased production costs.

The conflict created geopolitical tensions and uncertainties, affecting trade relationships and international cooperation in the flavonoid glycosides market. Trade disruptions, tariffs, and export restrictions imposed by involved parties disrupted the flow of raw materials and finished products. This limited market access and increased trade barriers, negatively impacting market growth.

By Type

  • Quercetin-3-O-rutinoside (Q-rut)
  • Quercetin-3-O-galactoside (Q-gal)
  • Quercetin-3-O-glucoside (Q-glc)
  • Quercetin-3-O-glucuronide (Q-glr)
  • Kaempferol-3-O-glucoside (K-glc)
  • Others

By Source

  • Citrus Fruit
  • Buckwheat
  • Onions
  • Others

By Application

  • Anticancer
  • Antioxidant
  • Anti-inflammatory
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • On January 15, 2024, The Department of Food Chemistry and Biocatalysis at UPWr announced funding for its pioneering project through the 14th edition of the National Centre for Research and Development's "Leader" program. The innovative project, titled "Flavonoid Glycosides with a Chlorine Atom: Multifunctional, Natural Preserving Agents in Cosmetic Products," has been granted nearly 1.8 million PLN from the NCBR.
  • On December 12, 2023, Florida A&M University (FAMU) announced a groundbreaking discovery: flavonoids, natural compounds commonly found in fruits and vegetables, may present a promising new treatment avenue. It is the remarkable aspect of these compounds is their non-toxic nature and their potential to combat chemotherapy resistance in breast cancer patients.
  • On October 18, 2023, Taiyo's revolutionary enzymatic technology, the SunActive flavonoid delivery system, announced a significant leap forward for the dietary supplement industry. This patented, solvent-free innovation is enhancing the industry's capacity to introduce more potent and effective ingredients to the market, marking a significant advancement in product efficacy and quality.

Competitive Landscape

The major global players in the flavonoid glycosides market include Merck KGaA, Lifecare Neuro Products Limited, Indena S.p.A., Cayman Chemical Company, Extrasynthese, INDOFINE Chemical Company, Inc., SMPNutra, Taylor & Francis Group, LLC., Ayur-vana, and Ingredion Incorporated.

Why Purchase the Report?

  • To visualize the global flavonoid glycosides market segmentation based on type, source, application, and region, as well as understand critical commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous flavonoid glycosides market-level data points with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of critical products of all the major players.

The global flavonoid glycosides market report would provide approximately 62 tables, 57 figures, and 213 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

Table of Contents

1.Methodology and Scope

  • 1.1.Research Methodology
  • 1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

  • 3.1.Snippet by Type
  • 3.2.Snippet by Source
  • 3.3.Snippet by Application
  • 3.4.Snippet by Region

4.Dynamics

  • 4.1.Impacting Factors
    • 4.1.1.Drivers
      • 4.1.1.1.Rising Demand for Functional Foods and Nutraceuticals
      • 4.1.1.2.Expanding Applications in the Pharmaceutical Industry
    • 4.1.2.Restraints
      • 4.1.2.1.Limited Availability of Raw Materials
    • 4.1.3.Opportunity
    • 4.1.4.Impact Analysis

5.Industry Analysis

  • 5.1.Porter's Five Force Analysis
  • 5.2.Supply Chain Analysis
  • 5.3.Pricing Analysis
  • 5.4.Regulatory Analysis
  • 5.5.Russia-Ukraine War Impact Analysis
  • 5.6.DMI Opinion

6.COVID-19 Analysis

  • 6.1.Analysis of COVID-19
    • 6.1.1.Scenario Before COVID
    • 6.1.2.Scenario During COVID
    • 6.1.3.Scenario Post COVID
  • 6.2.Pricing Dynamics Amid COVID-19
  • 6.3.Demand-Supply Spectrum
  • 6.4.Government Initiatives Related to the Market During Pandemic
  • 6.5.Manufacturers Strategic Initiatives
  • 6.6.Conclusion

7.By Type

  • 7.1.Introduction
    • 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2.Market Attractiveness Index, By Type
  • 7.2.Quercetin-3-O-rutinoside (Q-rut) *
    • 7.2.1.Introduction
    • 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3.Quercetin-3-O-galactoside (Q-gal)
  • 7.4.Quercetin-3-O-glucoside (Q-glc)
  • 7.5.Quercetin-3-O-glucuronide (Q-glr)
  • 7.6.Kaempferol-3-O-glucoside (K-glc)
  • 7.7.Others

8.By Source

  • 8.1.Introduction
    • 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 8.1.2.Market Attractiveness Index, By Source
  • 8.2.Citrus Fruit*
    • 8.2.1.Introduction
    • 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3.Buckwheat
  • 8.4.Onions
  • 8.5.Others

9.By Application

  • 9.1.Introduction
    • 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2.Market Attractiveness Index, By Application
  • 9.2.Anticancer*
    • 9.2.1.Introduction
    • 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3.Antioxidant
  • 9.4.Anti-inflammatory
  • 9.5.Others

10.By Region

  • 10.1.Introduction
    • 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2.Market Attractiveness Index, By Region
  • 10.2.North America
    • 10.2.1.Introduction
    • 10.2.2.Key Region-Specific Dynamics
    • 10.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1.U.S.
      • 10.2.6.2.Canada
      • 10.2.6.3.Mexico
  • 10.3.Europe
    • 10.3.1.Introduction
    • 10.3.2.Key Region-Specific Dynamics
    • 10.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1.Germany
      • 10.3.6.2.UK
      • 10.3.6.3.France
      • 10.3.6.4.Italy
      • 10.3.6.5.Russia
      • 10.3.6.6.Rest of Europe
  • 10.4.South America
    • 10.4.1.Introduction
    • 10.4.2.Key Region-Specific Dynamics
    • 10.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1.Brazil
      • 10.4.6.2.Argentina
      • 10.4.6.3.Rest of South America
  • 10.5.Asia-Pacific
    • 10.5.1.Introduction
    • 10.5.2.Key Region-Specific Dynamics
    • 10.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1.China
      • 10.5.6.2.India
      • 10.5.6.3.Japan
      • 10.5.6.4.Australia
      • 10.5.6.5.Rest of Asia-Pacific
  • 10.6.Middle East and Africa
    • 10.6.1.Introduction
    • 10.6.2.Key Region-Specific Dynamics
    • 10.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

11.Competitive Landscape

  • 11.1.Competitive Scenario
  • 11.2.Market Positioning/Share Analysis
  • 11.3.Mergers and Acquisitions Analysis

12.Company Profiles

  • 12.1.Merck KGaA*
    • 12.1.1.Company Overview
    • 12.1.2.Product Portfolio and Description
    • 12.1.3.Financial Overview
    • 12.1.4.Key Developments
  • 12.2.Merck KGaA
  • 12.3.Lifecare Neuro Products Limited
  • 12.4.Indena S.p.A.
  • 12.5.Cayman Chemical Company
  • 12.6.Extrasynthese
  • 12.7.INDOFINE Chemical Company, Inc.
  • 12.8.SMPNutra
  • 12.9.Taylor & Francis Group, LLC.
  • 12.10.Ayur-vana
  • 12.11.Ingredion Incorporated [List not Exhaustive]

LIST NOT EXHAUSTIVE

13.Appendix

  • 13.1.About Us and Services
  • 13.2.Contact Us